Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2026-02-20 @ 3:44 AM
Study NCT ID:
NCT02586168
Status:
COMPLETED
Last Update Posted:
2020-04-09
First Post:
2015-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects
Sponsor:
NeuroBo Pharmaceuticals Inc.
Organization:
Study Overview
Official Title:
The Effect of Gemcabene (CI-1027) on Insulin Sensitivity in Nondiabetic Subjects
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effect of gemcabene on insulin sensitivity as defined by average glucose disposal rate.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: